PROSTATE CANCER METASTATIC DISEASE
Clinical trials for PROSTATE CANCER METASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC DISEASE trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glow-in-the-Dark dye could help surgeons remove all prostate cancer
Diagnosis CompletedThis study tests a special dye that makes prostate cancer cells glow during surgery. About 22 men with aggressive prostate cancer will receive the dye before their prostate removal surgery. Surgeons will use a special camera to see the glowing cancer, helping them remove more of …
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Clinton Bahler • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
New imaging agent shows promise for prostate cancer detection
Diagnosis CompletedThis study tested a new radioactive imaging agent called 68Ga-OncoACP3 in 20 men with prostate cancer. The goal was to see if it is safe and to measure how much radiation the body receives. The agent helps doctors see where cancer has spread using a special scan.
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Could a common ED drug shield prostate cancer patients from chemo nerve pain?
Prevention CompletedThis study tested whether tadalafil, a drug often used for erectile dysfunction, can prevent nerve damage caused by docetaxel chemotherapy in men with metastatic prostate cancer. 90 participants were randomly assigned to receive either tadalafil plus standard care or standard car…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Tri-Service General Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC